Mineral bone disease in autosomal dominant polycystic kidney disease
Authors:
- 11 September 2020
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 99 (4) , 977-985
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 33 references indexed in Scilit:
- Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophyJournal of Bone and Mineral Research, 2012
- Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in miceThe FASEB Journal, 2011
- Role of the polycytin‐primary cilia complex in bone development and mechanosensingAnnals of the New York Academy of Sciences, 2010
- The HALT Polycystic Kidney Disease TrialsClinical Journal of the American Society of Nephrology, 2010
- Conditional Disruption of Pkd1 in Osteoblasts Results in Osteopenia Due to Direct Impairment of Bone FormationJournal of Biological Chemistry, 2010
- Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney diseaseBone, 2009
- Chronic Renal Insufficiency Cohort (CRIC) StudyClinical Journal of the American Society of Nephrology, 2009
- Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked HypophosphatemiaNew England Journal of Medicine, 2003
- PKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane ProteinScience, 1996
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987